Company profile
ReCode Therapeutics
Powering the next wave of genetic medicines through superior delivery
- Industry
- Biotechnology Research
- Employees
- 54
- Headquarters
- Menlo Park, California & Durham, North Carolina
- Founded
- 2015
- Office locations
- 1
ReCode Therapeutics company summary
ReCode Therapeutics is a company in the Biotechnology Research industry, headquartered in Menlo Park, California & Durham, North Carolina, founded in 2015. On LinkedIn the company has around 54 employees. Its listed specialties include RNA Therapies, Genetic Medicines, Non-Viral Lipid Nanoparticles, Genetic Respiratory Disease, Cystic Fibrosis.
What technology does ReCode Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About ReCode Therapeutics
ReCode Therapeutics is a clinical-stage genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics. ReCode’s selective organ targeting (SORT) lipid nanoparticle (LNP) platform is a next-generation, genetic medicines technology that enables precise delivery to target organs and cells beyond the liver.
Specialties
Where is ReCode Therapeutics located?
ReCode Therapeutics lists 1 location.
Compare companies similar to ReCode Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
ReCode Therapeutics recodetx.com | Biotechnology Research | 54 | 2015 | Menlo Park, California & Durham, North Carolina |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about ReCode Therapeutics
What does ReCode Therapeutics do?
ReCode Therapeutics is a clinical-stage genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics. ReCode’s selective organ targeting (SORT) lipid nanoparticle (LNP) platform is a next-generation, genetic medicines technology that enables precise delivery to target organs and cells beyond the liver.
How many employees does ReCode Therapeutics have?
ReCode Therapeutics has around 54 employees on LinkedIn.
Where is ReCode Therapeutics headquartered?
ReCode Therapeutics is headquartered in Menlo Park, California & Durham, North Carolina.
When was ReCode Therapeutics founded?
ReCode Therapeutics was founded in 2015.
Build a lead list from companies like ReCode Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.